Perioperative Ketamine for Pain With Gastric Bypass
Low-dose Ketamine Infusions for Perioperative Pain Management in Patients Undergoing Laparoscopic Gastric Bypass
Sponsor: Mayo Clinic
This PHASE2 trial investigates Ketamine and Laparoscopic Gastric Bypass Surgery and is currently completed. Mayo Clinic leads this study, which shows 13 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
May 2021 — Dec 2022 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
▶ Show 8 earlier versions
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
Status: Enrolling By Invitation → Active Not Recruiting
-
Aug 2019 — Mar 2020 [monthly]
Enrolling By Invitation PHASE2
-
Jun 2019 — Aug 2019 [monthly]
Enrolling By Invitation PHASE2
Status: Suspended → Enrolling By Invitation
-
May 2019 — Jun 2019 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
-
Jun 2018 — May 2019 [monthly]
Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Mar 2018 — May 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .